Evidence map›Paper›PMID 20052673›Full record

ArticleJournal of cellular biochemistry2010

Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.

Zhiwei Wang, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Aamir Ahmad, Veronique Nogueira, Nissim Hay, Fazlul H Sarkar

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Journal of cellular biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 203 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Reposition of the anti-inflammatory drug diacerein in anSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. MiR-769 Inhibits Colorectal Cancer Cell Proliferation and Invasion by Targeting HEY1.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  18. Article
  19. Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhiwei WangDepartment of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA. zhiweiwang@med.wayne.edu
Yiwei Li
Sanjeev Banerjee
Dejuan Kong
Aamir Ahmad
Veronique Nogueira
Nissim Hay
Fazlul H Sarkar
Wayne State University · USUniversity of Illinois Chicago · US

Funding

Molecular Mechanism of Genistein (Isoflavone) in Prostate CancerR01CA083695 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2001 to 2011
$2.3M
Targeting Akt/NF-kappa beta for Pancreatic Cancer TherapyR01CA101870 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2003 to 2007
$1.6M
NCI NIH HHS 1R01CA101870NCI NIH HHS 5R01CA083695
6 · The paper itself

Abstract

Notch signaling is involved in a variety of cellular processes, such as cell fate specification, differentiation, proliferation, and survival. Notch-1 over-expression has been reported in prostate cancer metastases. Likewise, Notch ligand Jagged-1 was found to be over-expressed in metastatic prostate cancer compared to localized prostate cancer or benign prostatic tissues, suggesting the biological significance of Notch signaling in prostate cancer progression. However, the mechanistic role of Notch signaling and the consequence of its down-regulation in prostate cancer have not been fully elucidated. Using multiple cellular and molecular approaches such as MTT assay, apoptosis assay, gene transfection, real-time RT-PCR, Western blotting, migration, invasion assay and ELISA, we found that down-regulation of Notch-1 or Jagged-1 was mechanistically associated with inhibition of cell growth, migration, invasion and induction of apoptosis in prostate cancer cells, which was mediated via inactivation of Akt, mTOR, and NF-kappaB signaling. Consistent with these results, we found that the down-regulation of Notch-1 or Jagged-1 led to decreased expression and the activity of NF-kappaB downstream genes such as MMP-9, VEGF, and uPA, contributing to the inhibition of cell migration and invasion. Taken together, we conclude that the down-regulation of Notch-1 or Jagged-1 mediated inhibition of cell growth, migration and invasion, and the induction of apoptosis was in part due to inactivation of Akt, mTOR, and NF-kappaB signaling pathways. Our results further suggest that inactivation of Notch signaling pathways by innovative strategies could be a potential targeted approach for the treatment of metastatic prostate cancer.

Indexed as

Cell MovementCell ProliferationApoptosisCalcium-Binding ProteinsCell Line, TumorDown-RegulationHumansIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsJagged-1 ProteinMaleMembrane ProteinsNeoplasm InvasivenessNF-kappa BProstatic NeoplasmsProtein Serine-Threonine KinasesCalcium-Binding ProteinsIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsJAG1 protein, humanJagged-1 ProteinMembrane ProteinsMTOR protein, humanNF-kappa BProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktReceptor, Notch1Serrate-Jagged ProteinsTOR Serine-Threonine Kinases

Identifiers

PMID20052673
OpenAlexW2095904711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.